Avadel Pharma says its sleep disorder drug remains under FDA review - Reuters

Reuters | Sept. 12, 2024, 8:22 a.m. | Original
Avadel Pharma says its sleep disorder drug remains under FDA review Reuters
ECB cuts interest rates as growth dwindles - Reuters.com Chemicals maker Dow lowers Q3 revenue forecast on unplanned event in Texas plant - Reuters.com